We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Adverse Reactions to Antibiotics Cause Thousands of ER Visits

By HospiMedica International staff writers
Posted on 03 Sep 2008
Adverse events from antibiotics cause an estimated 142,000 emergency room (ER) visits per year in the United States alone, according to a new study.

Researchers from the U.S. More...
Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) examined data from the U.S. National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance (NEISS-CADES) project--a sample of 63 hospitals in the United States and its territories--to estimate and compare the numbers and rates of adverse events from systemic antibiotics by class, drug, and event type. Based on 6,614 cases, the researchers estimated that 142,505 visits annually were made to ERs for drug-related adverse events attributable to systemic antibiotics.

The researchers found that 50% of the ER visits were for reactions to penicillin derivatives, and the other 50% were from reactions to other antibiotics used to treat a wide variety of bacterial infections. Compared with all other antibiotic classes, sulfonamides were associated with a significantly higher rate of moderate-to-severe allergic reactions, and sulfonamides and fluoroquinolones were associated with a significantly higher rate of neurologic or psychiatric disturbances. Almost 80% of all antibiotic adverse events in the study were allergic reactions, ranging from rash to anaphylaxis, and the remaining 20% were caused by medication errors and overdoses. The researchers found that only 6% of the patients who had adverse events required hospitalization. Children less than one-year-old were found to have the highest rate of adverse drug events. The study was published in the September 15, 2008, issue of the journal Clinical Infectious Diseases.

"For conditions in which antibiotics have questionable benefit, such as many mild upper respiratory tract infections, weighing the benefits of antibiotics with the risks of a serious adverse event will be especially important,” said study author Daniel Budnitz, M.D., of the U.S. National Center for Detection, Preparedness, and Control of Infectious Diseases at the CDC. "Because antibiotics are frequently used, both appropriately and inappropriately, if doctors would reduce the number of antibiotics they prescribe to their patients by even a small percentage, we could significantly reduce the number of emergency visits for antibiotic adverse events. Physicians need to communicate to their patients that antibiotics are not harmless.”

Related Links:
Centers for Disease Control and Prevention

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.